tykhr
sign in
free sign up
VistaGen Therapeutics Inc
Biotechnology
Healthcare
VTGN
30.63 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
2.00
52 week high
3.94
high
2.15
52 week low
2.03
low
1.90
growth
-46.63 %
previous Close
2.03
P/E ratio
market cap
71.00 M
div yield
0
usd
Sep 2024
qoq
revenue
183 K
117.86 %
net incoming
-12.96 M
-20.76 %
eps
0.00 %
-20.00 %
eps surprise
-7.69 %
net profit margin
-7082.51 %
5694.00 %
operating incoming
-14.23 M
-17.28 %
net change in cash
-18.67 M
-14.92 %
cash on hand
84.25 M
-18.14 %
cost of revenue
0.00 %
top